In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TearScience brings in $44.5mm in Series C money

Executive Summary

TearScience Inc. (devices to monitor and treat dry eye) has raised $44.5mm through its Series C venture round. New backers Essex Woodlands Health Ventures, Investor Growth Capital, and General Catalyst will each contribute one board member and were joined by returning shareholders De Novo Ventures, Spray Ventures, and Quaker BioVentures.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies